MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

504435

Report Date :

19.04.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

ANTHEM BIOSCIENCES PRIVATE LIMITED

 

 

Registered Office :

No.49, F1 and F2, Canara Bank Road, Bommsandara Industrial Area, Phase - I, Hosur Road, Bangalore – 560099, Karnataka

Tel. No.:

91-80-66724000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

13.06.2006

 

 

Com. Reg. No.:

08-039703

 

 

Capital Investment / Paid-up Capital :

INR 107.114 Million

 

 

CIN No.:

[Company Identification No.]

U24233KA2006PTC039703

 

 

IEC No.:

[Import-Export Code No.]

0706014120

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAFCA7588P

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. (Registered Activity)

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 5450000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2006 and it is having good track.

 

For the financial year 2017, the company has increased in its revenue from operations as compared to previous year and maintained decent profit margin of 21.24%.

 

Rating takes into consideration sound financial profile of the company marked by healthy networth base and low debt balance sheet.

 

Rating also derives strength from its presence in a niche product segment as well as its strong past tract records, promoter background along with technical competence supported by a robust R&D infrastructure and improvement in the revenue as well as profitability profile during the year.

 

Trade relations are reported as fair. Business is active. Payments are seems to be regular.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Long Term Rating=A-

Rating Explanation

Adequate degree of safety and low credit risk.

Date

22.03.2018

 

Rating Agency Name

ICRA

Rating

Short Term Rating=A2+

Rating Explanation

Strong degree of safety and low credit risk.

Date

22.03.2018

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 19.04.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Krishnan Ramakrishnan

Designation :

Company Secretary

Contact No.:

91-80-66724000

Date :

18.04.2018

 

 

LOCATIONS

 

Registered Office :

No.49, F1 and F2, Canara Bank Road, Bommsandara Industrial Area, Phase - I, Hosur Road, Bangalore – 560099, Karnataka, India

Tel. No.:

91-80-66724000/ 49

Fax No.:

91-80-66724020

E-Mail :

ramkrishnan.k@anthembio.com

bd@anthembio.com

purchase@anthembio.com

hr@anthembio.com

Website :

www.anthembio.com

 

 

Factory :

Located at:

 

  • Bommasandra Industrial Area (Bangalore)

 

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Ajay Bhardwaj

Designation :

Managing Director

Address :

No. 717, 16th Main, 3rd Block, Koramangala, Bangalore - 560034, Karnataka, India

Date of Birth/Age :

20.07.1960

Date of Appointment :

13.06.2006

DIN No.:

00333704

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U85110KA1991PTC012478

ANTHEM CELLUTIONS (INDIA) PRIVATE LIMITED

01/04/2008

-

U24232KA2008PTC047934

WEISS BIOTECH PRIVATE LIMITED

03/10/2008

-

U24232KA2009PTC051551

ANTHEM BIO PHARMA PRIVATE LIMITED

30/09/2011

-

 

 

Name :

Mr. Sambasivam Ganesh

Designation :

Director

Address :

No. 1840, 14th Cross, 22nd Main, Sector I, HSR Layout, Bangalore - 560034, Karnataka, India

Date of Birth/Age :

20.12.1965

Date of Appointment :

04.08.2006

DIN No.:

01469963

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U85110KA1991PTC012478

ANTHEM CELLUTIONS (INDIA) PRIVATE LIMITED

09/11/2006

-

 

 

Name :

Mr. Koramangala Chandrappa Ravindra

Designation :

Director

Address :

276, II Cross, Cambridge Layout, Ulsoor, Bangalore - 560008, Karnataka, India

Date of Birth/Age :

02.11.1966

Date of Appointment :

27.09.2006

DIN No.:

01580534

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U85110KA1991PTC012478

ANTHEM CELLUTIONS (INDIA) PRIVATE LIMITED

09/11/2006

-

U24232KA2008PTC047934

WEISS BIOTECH PRIVATE LIMITED

03/10/2008

-

 

 

 

KEY EXECUTIVES

 

Name :

Mr. Krishnan Ramakrishnan

Designation :

Company Secretary

Address :

A 301, Terrace Garden, 2nd Main 100 Feet Road Banashankar III Stage, Bangalore - 560085, Karnataka, India

Date of Birth/Age :

01.02.1962

Date of Appointment :

21.07.2008

PAN No.:

AAMPR6644K

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2017

 

Names of Shareholders (Equity Shares)

 

No. of Shares

Ajay Bhardwaj

 

4680000

Ganesh Sambasivam

 

1179442

Ravindra Koramangala Chandrappa

 

1179442

Portsmouth Technologies LLC

 

330000

Malay Jiban Baru

 

336983

Rupesh Naraharao Kinekar

 

336983

Satish Sharma

 

336983

Total

 

8379833

 

Names of Shareholders (Preference Shares)

 

No. of Shares

Portsmouth Technologies LLC

 

23316

Total

 

23316

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 29.09.2017

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family-Indian)

84.00

Public/Other than promoters (Individual/Hindu Undivided Family-Indian)

12.06

Public/Other than promoters (Body corporate)

3.94

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. (Registered Activity)

 

 

Products/ Services :

Item Code No.

Product/ Services Description

29214590

BENZYLOXY

CARBONYL

ETHYL DIHYDRO

PYR

29141990

GALNAC

INTERMEDIATE

12C

29362930

VITAMIN K

29335990

5-HYDROXY

29049090

DIOL

29225090

ETHNYL-DIMETHOXYTETRAHYDRO

29199090

F LUORO

METHOXY

NITROANILINE

29333990

PYRROLOQUINOLINE

QUINONE BIS

SODIUM SALT (PQQ

BIS SODIUM SALT)

29350090

AMINOACETYL AMINO

METHYL

29420090

VOGLIBOSE

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

HDFC Bank Limited

Branch

HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400013, Maharashtra, Indi a

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Rupee term loans from banks

1197.692

545.660

Borrowing from government

semi-government bodies

32.228

0.000

Loans taken for vehicles

7.625

3.610

Short-term borrowings

 

 

Rupee term loans from banks

143.257

42.609

Loans repayable on demand from banks

172.680

223.270

Borrowing from government

semi-government bodies

1.174

0.000

Loans taken for vehicles

0.000

2.437

Total

1554.656

817.586

 

Auditors :

 

Name :

YVS Vinod and Associates

Chartered Accountants

Address :

Suite No 2, Farah Greens, No 10, Eagle Street, Langford Town, Bangalore, Karnataka, India

Income-tax PAN of auditor or auditor's firm :

AARFM1902G

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary Company :

Anthem Cellutions (India) Private Limited (CIN No.: U85110KA1991PTC012478)

 

 

Associate :

Anthem Bio Pharma Private Limited (CIN No.: U24232KA2009PTC051551)

 

 

 

 

 

CAPITAL STRUCTURE

 

After 29.09.2017

 

Authorised Capital : INR 325.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

8379833

Equity Shares

INR 10/- each

INR 83.798 Million

23316

Preference Shares

INR 1000/- each

INR 23.316 Million

 

Total

 

INR 107.114 Million

 

As on 29.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

INR 10/- each

INR 100.000 Million

25000

Preference Shares

INR 1000/- each

INR 25.000 Million

 

Total

 

INR 125.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

8379833

Equity Shares

INR 10/- each

INR 83.798 Million

23316

Preference Shares

INR 1000/- each

INR 23.316 Million

 

Total

 

INR 107.114 Million

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

107.114

83.798

83.798

(b) Reserves and Surplus

1801.157

1129.702

734.323

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1908.271

1213.500

818.121

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1506.388

772.483

431.908

(b) Deferred tax liabilities (Net)

0.000

0.000

18.486

(c) Other long-term liabilities

4.081

5.412

16.284

(d) long-term provisions

31.252

22.484

22.144

Total Non-current Liabilities (3)

1541.721

800.379

488.822

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

317.111

269.490

187.200

(b) Trade payables

274.727

154.847

164.977

(c) Other current liabilities

508.509

292.320

117.948

(d) Short-term provisions

163.414

196.561

75.595

Total Current Liabilities (4)

1263.761

913.218

545.720

 

 

 

 

TOTAL

4713.753

2927.097

1852.663

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

2393.545

681.716

701.578

(ii) Intangible Assets

20.696

5.284

2.731

(iii) Tangible assets capital work-in-progress

431.553

740.246

224.396

(iv) Intangible assets under development

11.152

11.151

0.000

(b) Non-current Investments

194.566

191.453

191.453

(c) Deferred tax assets (net)

5.324

13.278

0.000

(d) Long-term loans and advances

76.577

100.751

99.290

(e) Other Non-current assets

17.713

0.000

0.734

Total Non-Current Assets

3151.126

1743.879

1220.182

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

223.073

53.216

11.929

(b) Inventories

412.586

300.518

188.901

(c) Trade receivables

445.761

492.069

319.792

(d) Cash and bank balances

110.707

38.930

25.693

(e) Short-term loans and advances

352.354

295.395

86.166

(f) Other current assets

18.146

3.090

0.000

Total Current Assets

1562.627

1183.218

632.481

 

 

 

 

TOTAL

4713.753

2927.097

1852.663

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

2722.649

2091.354

1617.786

 

Other Income

58.291

40.509

24.666

 

TOTAL

2780.940

2131.863

1642.452

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

804.848

682.210

567.701

 

Purchases of Stock-in-Trade

0.000

0.000

0.000

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

2.051

(41.585)

42.385

 

Employee benefit expense

514.157

379.109

290.005

 

CSR expenditure

0.000

0.287

0.000

 

Other expenses

468.480

341.653

242.871

 

Prior period items before tax

0.690

1.056

1.400

 

TOTAL

1790.226

1362.730

1144.362

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

990.714

769.133

498.090

 

 

 

 

 

Less

FINANCIAL EXPENSES

36.031

24.755

31.900

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

954.683

744.378

466.190

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

205.722

184.403

89.931

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

748.961

559.975

376.259

 

 

 

 

 

Less

TAX

170.554

153.486

117.295

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

578.407

406.489

258.964

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE

BROUGHT FORWARD

990.839

624.999

391.935

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

Transfer to Capital Redemption Reserve

57.841

40.649

25.900

 

Dividend on Pref. Shares(proposed)

0.012

0.000

0.000

 

Tax on preference dividend

0.002

0.000

0.000

 

 

 

 

 

 

Balance Carried to the B/S

1511.391

990.839

624.999

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

2732.086

1858.042

1309.200

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

0.000

0.000

271.170

 

TOTAL IMPORTS

0.000

0.000

271.170

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

68.83

48.51

30.90

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

847.870

529.361

250.115

Net cash flow from operating activity

847.870

316.574

215.115

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

59.76

85.88

72.15

 

 

 

 

Account Receivables Turnover

( Income / Sundry Debtors)

6.11

4.25

5.06

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

124.59

82.85

106.07

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

2.40

2.56

2.64

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.35

0.53

0.54

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.59

0.58

0.53

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.96

0.86

0.76

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.66

0.75

0.67

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

1.50

1.19

1.14

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

27.50

31.07

15.61

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

[(PAT / Sales) * 100]

%

21.24

19.44

16.01

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

12.27

13.89

13.98

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

30.31

33.50

31.65

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.24

1.30

1.16

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.91

0.97

0.81

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.40

0.41

0.44

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

17.02

12.43

7.39

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.24

1.30

1.16

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

83.798

83.798

107.114

Reserves & Surplus

734.323

1129.702

1801.157

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

818.121

1213.500

1908.271

 

 

 

 

Long-term borrowings

431.908

772.483

1506.388

Short term borrowings

187.200

269.490

317.111

Total borrowings

619.108

1041.973

1823.499

Debt/Equity ratio

0.757

0.859

0.956

 

 


 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1617.786

2091.354

2722.649

 

 

29.273

30.186

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

1617.786

2091.354

2722.649

Profit/ (Loss)

258.964

406.489

578.407

 

16.01 %

19.44 %

21.24 %

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

107.114

133.798

(b) Reserves and Surplus

 

2125.746

1375.461

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

2232.860

1509.259

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

1559.418

828.396

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

0.000

5.412

(d) long-term provisions

 

44.692

30.236

Total Non-current Liabilities (3)

 

1604.110

864.044

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

347.906

365.161

(b) Trade payables

 

333.650

258.867

(c) Other current liabilities

 

530.421

294.435

(d) Short-term provisions

 

47.626

268.836

Total Current Liabilities (4)

 

1259.603

1187.299

 

 

 

 

TOTAL

 

5096.573

3561.744

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

2499.569

794.478

(ii) Intangible Assets

 

83.568

66.567

(iii) Tangible assets capital work-in-progress

 

431.289

740.246

(iv) Intangible assets under development

 

11.152

11.152

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

(0.520)

7.864

(d) Long-term loans and advances

 

81.608

110.618

(e) Other Non-current assets

 

48.996

37.670

Total Non-Current Assets

 

3155.662

1768.595

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

266.709

84.464

(b) Inventories

 

578.554

466.715

(c) Trade receivables

 

737.772

838.042

(d) Cash and bank balances

 

111.476

40.357

(e) Short-term loans and advances

 

227.343

357.476

(f) Other current assets

 

19.057

6.095

Total Current Assets

 

1940.911

1793.149

 

 

 

 

TOTAL

 

5096.573

3561.744

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Total Revenue from operations

 

3559.602

3082.230

 

Other Income

 

68.796

48.167

 

TOTAL

 

3628.398

3130.397

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1258.041

1297.541

 

Purchases of Stock-in-Trade

 

74.422

31.542

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

10.348

(30.700)

 

Employee benefit expense

 

625.034

452.139

 

CSR expenditure

 

0.100

0.575

 

Other expenses

 

508.735

410.212

 

Prior period items before tax

 

0.726

0.560

 

Exceptional items before tax

 

0.000

0.983

 

TOTAL

 

2477.406

2162.852

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

1150.992

967.545

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

54.292

34.341

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

1096.700

933.204

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

215.184

205.154

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

881.516

728.050

 

 

 

 

 

Less

TAX

 

220.708

226.627

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

660.808

501.423

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

 

 

 

Basic

 

 68.03

59.37

 

Diluted

 

NA

37.18

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

GENERAL INFORMATION

 

The company has been set up as a Life sciences / Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries.

 

The Company has received the letter of permission under the 100% EOU scheme for manufacture of catalytic preparation and other organic compounds from the office of the Development Commissioner, CSEZ, sub office in Karnataka, vide letter No.1/80/2006:PER:EOU:KR:CSEZ/106 dated 19th January 2007, which is further extended vide letter No :1/80/2006:EOU:CSEZ/942 dated 18th June 2012 . In accordance with the said letter of permission, the facilities at the factory located at Bommasandra Industrial Area are with its best in class infrastructure which includes a modern c-GMP kilo lab and a versatile GMP pilot plant. Anthem Biosciences has the capacity to do GMP synthesis from milligram to kilogram and multi-kilogram scale. The projects results are initially transmitted by means of reports followed by the manufacture of small sample quantities that are sent to clients for testing purpose.

 

The Company has received approval from Department of Scientific and Industrial Research Technology for in-house research and development for the purpose of section 35 (2AB) of the Income Tax Act, 1961 beginning 1 April 2011 to 31 March 2017.

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Borrowing from government semi-government bodies

0.000

3.402

Loans and advances from related parties

268.843

219.811

Short-term borrowings

 

 

Borrowing from government semi-government bodies

0.000

1.174

Total

268.843

224.387

 

 

INDEX OF CHARGES

 

Charges Registered

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G49824725

100114200

HDFC BANK LIMITED

16/05/2017

-

-

750000000.0

HDFC BANK HOUSE SENAPATI BAPAT MARGLOWER PAREL WEST MUMBAI MAHARASHTRA 400013 INDIA

2

G37193992

100080421

BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL

14/02/2017

-

-

112110685.0

MTNL Building, 1st Floor,9 CGO Complex, Lodi Road New Delhi 110003 INDIA

3

G30614036

100067303

Syndicate Bank

21/10/2016

-

-

170000000.0

Mid Corporate Branch, Anand Bhavan1st Floor, Netkallappa Circle, Basavanagud Bangalore KARNATAKA 560004 INDIA

4

C77612612

10589525

Syndicate Bank

10/08/2015

08/01/2016

-

292400000.0

Mid Corporate Branch Bangalore, First floor,"Anand Bhavan" Netkallappa Circle, Market Road Bangalore KARNATAKA 560004 INDIA

5

C77783488

10589528

SYNDICATE BANK

10/08/2015

11/01/2016

-

95800000.0

Mid Corporate Branch Bangalore, First floor, "Anand Bhavan" Netkallappa Circle,Market Road Bangalore KARNATAKA 560004 INDIA

6

C66650516

10595739

CITI BANK N.A.

29/07/2015

-

-

120000000.0

2nd Floor, No.5, M.G.Road Bangalore KARNATAKA 560001 INDIA

7

C64670797

10589144

EXPORT-IMPORT BANK OF INDIA

27/05/2015

06/06/2015

-

450000000.0

CENTRE ONE BUILDING ,FLOOR 21, WORLD TRADE CENTRE CUFFE PARADE MUMBAI MAHARASHTRA 400005 INDIA

8

C49485055

10560143

Syndicate Bank

27/03/2015

-

-

750000000.0

Mid Corporate Branch Bangalore,First floor,"Anand Bhavan" Netkallappa Circle, Market Road Bangalore KARNATAKA 560004 INDIA

9

C10605095

10508137

Citi Bank N.A.

26/05/2014

-

-

100000000.0

2nd Floor, No.5,M. G. Road, BANGALORE KARNATAKA 560001 INDIA

10

C67215715

10049342

State Bank of India

11/03/2007

22/12/2014

15/10/2015

380600000.0

INDUSTRIAL FINANCE BRANCHRESIDENCY PLAZA, RESIDENCY ROAD BANGALORE KARNATAKA 560025 INDIA

 

 

 

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Office building
  • Factory building
  • Other building
  • Plant and equipment
  • Factory equipments
  • Other plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles
  • Office equipment
  • Computer equipments

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 65.68

UK Pound

1

INR 93.98

Euro

1

INR 81.30

 

 

INFORMATION DETAILS

 

Information Gathered by :

PNM

 

 

Analysis Done by :

PSD

 

 

Report Prepared by :

SUD

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.